salmeterol xinafoate has been researched along with Eosinophilic Esophagitis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Collison, AM; Fevre, AL; Foster, PS; Hansbro, PM; Mattes, J; Nightingale, S; Percival, E; Sokulsky, LA; Starkey, MR | 1 |
1 other study(ies) available for salmeterol xinafoate and Eosinophilic Esophagitis
| Article | Year |
|---|---|
TRAIL deficiency and PP2A activation with salmeterol ameliorates egg allergen-driven eosinophilic esophagitis.
Topics: Animals; Anti-Inflammatory Agents; Bronchodilator Agents; Case-Control Studies; Chemokine CCL11; Child; Cytokines; Dexamethasone; Egg Hypersensitivity; Eosinophilic Esophagitis; Female; Fibrosis; Humans; Interleukin-3; Interleukin-5; Male; Mice; Mice, Inbred BALB C; Microtubule Proteins; Nuclear Proteins; Ovalbumin; Protein Phosphatase 2; Salmeterol Xinafoate; Thymic Stromal Lymphopoietin; TNF-Related Apoptosis-Inducing Ligand; Transcription Factors; Ubiquitin-Protein Ligases | 2016 |